- Open Access
Interventions in randomised controlled trials in surgery: issues to consider during trial design
Trials volume 16, Article number: 392 (2015)
Until recently, insufficient attention has been paid to the fact that surgical interventions are complex. This complexity has several implications, including the way in which surgical interventions are described and delivered in trials. In order for surgeons to adopt trial findings, interventions need to be described in sufficient detail to enable accurate replication; however, it may be permissible to allow some aspects to be delivered according to local practice. Accumulating work in this area has identified the need for general guidance on the design of surgical interventions in trial protocols and reports. Key issues to consider when designing surgical interventions include the identification of each surgical intervention and their components, who will deliver the interventions, and where and how the interventions will be standardised and monitored during the trial. The trial design (pragmatic and explanatory), comparator and stage of innovation may also influence the extent of detail required. Thoughtful consideration of surgical interventions in this way may help with the interpretation of trial results and the adoption of successful interventions into clinical practice.
There has been an increasing recognition over the past decade that surgical interventions are complex [1–3]. Complex interventions have multiple components, which can act independently or inter-dependently to influence outcomes . The components of surgical interventions may include parts of the operation such as incising, resecting or closing. Surgical interventions are accompanied by concomitant interventions that can occur before, during or after surgery and also have several components - for example, delivering an anaesthetic or providing post-operative pain relief. Contextual factors such as the operating theatre environment, availability of certain equipment and the sheer volume of cases undertaken within a hospital can all influence outcomes and therefore contribute to the complexity. Finally, complex interventions such as surgery can be dependent on the skills of those delivering care (operator expertise), and this may also influence outcomes . Within randomised controlled trials (RCTs) of surgical interventions, it is therefore necessary to consider the surgical and concomitant interventions, contextual factors and operator expertise, and decide to what extent they need to be described and standardised within trial protocols .
The MRC (Medical Research Council) guidance for developing and evaluating complex interventions recommends that centres participating in RCTs ‘consistently provide as close to the same intervention as possible’ by ‘standardising the content and delivery of the intervention’. The guidance recommends identifying and piloting the key components of interventions before full evaluation within RCTs [6–8]. Whilst this may be helpful advice, how to operationalise this when designing RCTs in surgery remains unclear. The recent publication of the SPIRIT statement (Standard Protocol Items: Recommendations for Interventional Trials)  provides some guidance for describing interventions within trial protocols. It recommends that interventions are ‘described in detail so that they can be replicated in practice’, and states that details about ‘relevant concomitant care and interventions’ and ‘study settings where data will be collected’ be provided. Whether this means that every detail of a surgical operation, anaesthetic and aftercare should be described in the trial protocol is unclear. Providing such detailed descriptions may help to distinguish between the interventions in each trial group, ensuring that they are actually different from one another. For this reason, it may also improve systematic reviews of RCTs of similar surgical interventions. Conversely, however, it is possible that this level of detail is not always necessary or practical. Within large scale pragmatic trials, for example, less information may be required. Detailed descriptions may also fail to reflect the inherent variation in clinical practice and consequently reduce the generalisability of the results. A balance between ‘adequate’ descriptions of interventions and the practicality of delivery is necessary. Some guidance regarding how to go about this process when designing surgical interventions is needed.
The aim of this paper is to describe the key questions to consider during the design of an RCT involving surgical interventions. Issues will be illustrated with examples. This work arose from a 2-day MRC Hub for Trials Methodology Research Network workshop held in June 2013 led by the ConDuCT (Collaboration and Innovation in Difficult Randomised Controlled Trials, Bristol) and Biostatistics (Cambridge) Hubs.
Designing surgical interventions within RCTs
Questions to consider during the design of surgical interventions in RCTs are summarised in Table 1, with an accompanying glossary of terms in Table 2. Each item in Table 1 is illustrated below using the example of interventions for appendicitis. This example was chosen because appendicectomy is a common operation with several possible technical variations, and there is an established non-surgical alternative treatment (treatment with antibiotics). The questions address i) surgical interventions (items 1 and 2); ii) concomitant interventions (item 3); iii) how to describe, standardise and monitor surgical and concomitant interventions (items 4, 5 and 6); iv) operator expertise (item 7); and v) context (item 8).
Does the RCT involve at least one surgical intervention?
Initially, it is important to decide if the study in question is a surgical RCT. In this paper, a RCT in surgery is defined as evaluating a surgical intervention in at least one of the trial groups. A surgical intervention is defined as one that involves physically changing body tissues and organs through manual operation such as cutting, suturing, abrading or the use of lasers . Surgical interventions may be the main intervention under investigation or be a concomitant intervention. An example of the former might be the evaluation of open versus laparoscopic surgery for the treatment of appendicitis. Conversely, a trial comparing two different types of post-operative pain relief following surgery for appendicitis would represent an example of surgery as a concomitant intervention (because the main comparison is between the methods of pain relief rather than surgery). This paper will focus on issues to consider in the design of surgical interventions in RCTs in which they are the main intervention under evaluation. Work investigating how concomitant surgical interventions might be described in trial protocols will be addressed separately.
What are the surgical interventions under evaluation?
A recent systematic review examining reporting standards for surgical interventions found that 30 % of trials reported only the name of the intervention under investigation and gave no further written detail . Providing just the name of a surgical intervention, such as ‘appendicectomy’, leaves this open to different interpretations by different surgeons. It is therefore recommended that specific details of the intervention be clarified and agreed at the beginning of a trial, and described in more detail in trial publications. One way of achieving this is for the trial team to identify systematically all of the constituent components and steps of the surgical intervention during the trial design or pilot work. Examples of potential components and steps involved in performing an appendicectomy are described in Table 3. This identification process should also include any planned further operations; for example, elective two-staged liver resection involves two operations with an intervening interval of between 2 and 6 weeks. It is necessary to clearly state that there is a planned second operation, as well as the anticipated interval between the first and second operations.
Systematic documentation of all intervention components, from skin incision through to wound closure, would prevent potentially important aspects of the intervention from being overlooked. Additionally, the a priori identification of intervention details will help the trial team to clarify which components and/or steps are considered important to the research question, or the quality assurance of surgery. It will be essential to document and justify the extent of standardisation and monitoring required for such components/steps during the trial (see questions 4 and 5).
What are the concomitant interventions accompanying the surgical intervention?
Similar to surgical interventions themselves, concomitant interventions often comprise multiple components and these may require consideration during trial design. All of the potential concomitant interventions associated with the surgical intervention may need to be identified and listed during trial team meetings during the design phase (Table 4). Subsequently, the ‘key’ concomitant interventions (and their components) can be detailed within the trial protocol. This may include discussions about which of the concomitant interventions need to be standardised across all trial groups. Factors influencing the level of detail required are discussed below.
What will influence the amount of standardisation needed for the intervention?
Key questions to consider are illustrated with published examples in Table 5.
What is the overall trial design?
The overall design and purpose of the trial will influence the extent to which interventions are standardised. Explanatory trials (defined in Table 2), which determine the efficacy of interventions, are likely to require detailed intervention descriptions and strict standardisation of delivery. Because explanatory trials often involve just a few centres or surgeons, tend to have a less varied patient cohort, and may be conducted by the surgeons responsible for developing the novel procedure, this may be possible to achieve. Conversely, pragmatic designs (defined in Table 2) determine whether interventions are effective in a more general setting, and therefore usually involve large numbers of surgeons and centres. Under such circumstances, ensuring tight control over intervention delivery is likely to be difficult and may be undesirable given the pragmatic design. Although a less detailed description of the intervention may be required in the trial protocol, those components that are considered to be ‘key’, or those that are crucial in distinguishing the interventions between trial groups, should be reported as a minimum.
What type of comparator is in the study?
It is important to establish how the surgical intervention under investigation is different to treatment within the other trial groups. For example, in a trial comparing a surgical and non-surgical intervention (surgery versus antibiotics for appendicitis), a detailed description of the operation may not be required because the key difference between the interventions are immediately apparent. In a trial comparing two perations for appendicitis (for example, laparoscopic and single-port appendicectomy), the interventions are more similar to each other. It may therefore be important to clarify the expected differences in intervention delivery between the two groups (for example, the number and size of laparoscopic ports), to describe these in the protocol and monitor their delivery during the trial.
What stage of development is the intervention?
The stage of development of an intervention may influence the amount of detail required in the trial protocol. The IDEAL (Idea-Development-Exploration-Assessment-Long term study) guidance provides a framework for the staged development and evaluation of novel surgical interventions [1–3]. In stage 2b, pilot work is recommended prior to rolling out an effectiveness trial because the intervention may be still evolving. In this type of pilot study it is likely that extensive detail regarding the intervention needs to be documented and strict standardisation of the intervention mandated, along with explicit reporting of any changes implemented and the rationale behind them. In IDEAL Stage 3 RCTs, the extent to which interventions need to be described and standardised may depend more upon the overall trial design (pragmatic versus explanatory approaches - see above).
How will the intervention(s) be standardised in the RCT?
Standardisation of surgical interventions relates to the extent to which trial protocols specify exactly how they should be delivered. Several factors may influence the amount of standardisation that may be required, such as the overall trial design and research objective, and these are considered in question 4. The process of deciding how much standardisation is necessary starts during trial design, with the trial team identifying all of the constituent components and steps of each intervention (questions 2 and 3). Once the components and steps have been listed, details about exactly how they should be performed can be established. For example, trialists can decide whether each of the components and steps are mandatory, prohibited or optional [12, 13]. Subsequently, they can consider whether the components and steps should be performed in a specific way, or flexibly (that is, according to individual surgeon preferences). An example of a trial in which standardisation of the surgical interventions was unclear, subsequently leading to a published debate, is provided in Table 6.
It may be very difficult to standardise completely the ‘form’ of complex interventions such as surgery - that is, all of the components. One potential compromise would be to standardise an intervention’s key ‘functions’ rather than specifying the specific ‘form’ it needs to take. Standardisation of surgical interventions in trial protocols may, therefore, range from completely flexible delivery of the entire intervention to rigid standardisation of every step. In appendicectomy, for example, it may simply be stated that the appendix be removed (that is, standardisation of ‘function’ only), meaning this can be performed with robotic or minimal access techniques, or using an open incision. Even if complete flexibility is allowed, this should be stated explicitly to avoid doubt. The other extreme - where an intervention is rigidly standardised in a trial - requires extensive details to be provided within the trial protocol. This would include information about each of the mandatory, optional and prohibited components and steps of the intervention (that is, standardisation of ‘function’ and ‘form’) and delivery of these would be monitored strictly during the trial itself.
Will intervention delivery be monitored during the trial? If so, how?
During a trial, it may be necessary to assess whether the intervention was delivered as intended (fidelity). Fidelity has been defined as ‘how far those responsible for delivering an intervention actually adhere to the intervention as it is outlined by its designers’ . The degree to which intervention fidelity needs to be monitored within RCTs will largely depend upon the extent to which the trial protocol prescribes standardisation. For example, if it is decided that certain components or steps of an operation are essential, monitoring of these components to see if they are delivered as planned will be important. In addition, it may be necessary to monitor whether prohibited steps were performed in error during the trial. Assessing whether key components of an intervention are actually performed according to protocol can be challenging and may require video or photographic evidence, direct observation or surgeon-reported descriptions of what was done . If fidelity is found to be lacking within a trial taking an explanatory approach, active steps might be taken to improve this including additional training or withdrawal of surgeons. Conversely, in trials with a more flexible protocol, monitoring of the delivery of interventions may not be required, particularly if the trial protocol clearly states that these steps can be carried out according to surgeons’ preferred techniques. One limitation of this pragmatic approach would be the potential loss of documentation of fidelity, which can be helpful in summarising the range of techniques used and in interpretation of trial results.
Who will deliver the interventions?
Surgical interventions are not usually delivered by a single surgeon working in isolation. Instead, they are typically supported by one or more surgeon colleagues and a surgical team (for example, nurses and anaesthetists). The skills of all these team members may influence treatment outcomes, and it may be necessary to account for them in RCTs evaluating surgical interventions, both at the design and analysis stage . Some surgical interventions may be more dependent on particular expertise than others (see question 4), and a discussion of these issues during trial design is recommended. If the delivery of a surgical intervention is considered to be heavily dependent on expertise, or requires a step-change in technical skill, it may be necessary to set pre-defined entry criteria for surgeons such as a minimum annual caseload, attendance of training courses, number of years in training, or outcome data thresholds . Alternatively, it may be possible to account for expertise within trial design using expertise-based RCTs  or the detection and modelling of learning curves . In other circumstances, for example more pragmatic trial designs, formal minimal criteria for surgeons’ expertise beyond what is required in routine practice may be of limited value. This is contentious, however, as some consider that trials should never involve ‘novice’ surgeons who are still learning techniques, irrespective of the overall design, because the results may be interpreted as less convincing.
Where will the interventions be delivered?
Context can be defined as the distinctive features of an intervention’s setting, participants and delivery . In surgical RCTs, this may include the type of hospital and department (for example, tertiary centre versus district general hospital) as well as features of the surgical teams (for example, specialists versus generalists). Whilst context may be more relevant in some RCTs than others (see question 4), it is recommended that all trials consider and describe whether there are any elements of context that were important for the delivery of the trial or that may have had an impact on the effect of the intervention. In some circumstances, it may be necessary to set pre-defined criteria regarding context, such as centre volume or constituent members of the multi-disciplinary team responsible for delivering the surgical interventions.
This paper identifies key questions relevant to the design and reporting of surgical interventions in RCTs in surgery. The questions cover issues relating to intervention description, standardisation and monitoring, expertise of surgical teams, and the context of intervention delivery. Consideration of these issues is recommended so that appropriate levels of detail about interventions, and methods for monitoring their delivery, can be documented in the trial protocol and can be subsequently assessed during the trial itself. This may go some way to reduce the criticisms currently levelled at the heterogeneous delivery of interventions within RCTs in surgery.
Since the workshop in which these issues were discussed took place, the TIDieR (Template for Intervention Description and Replication) checklist has been published . TIDieR provides guidance for describing interventions within RCTs, recommending that information other than just the name of the intervention be reported. The authors state that ‘the overarching purpose of the TIDieR checklist is to prompt authors to describe interventions in sufficient detail to allow their replication’. Items within TIDieR include consideration of the processes involved in the intervention, the mode of delivery and any context and expertise requirements. Although these items are helpful in surgical settings, TIDieR is not specific to a particular intervention type. This means that some of the checklist items may be less relevant to surgery, for example, intervention duration, dose and the number of times delivered. Additionally, there may be important omissions for describing complex interventions. For example, TIDieR does not include concomitant interventions that may be particularly relevant for interventions such as surgery. Although the guidance states that interventions should be described in sufficient detail to allow replication, it does not discuss potential circumstances that may remove the need for such in-depth information, such as study design (for example, pragmatic versus explanatory approach) or the stage of innovation of the intervention (for example, ‘established versus ‘new’ procedures).
This paper recommends that trialists list all the components and steps of surgical interventions in a thorough and logical way, and then identify which components need to be standardised. It does not, however, explore how the key components might be identified if they are not obvious after all of the intervention components and steps have been listed. Whilst this can be informed by discussion and meetings, it is an area that needs further work. There are several potential methods for determining the key components of surgical interventions. These include surveys of literature and current practice, consensus methods to reach agreement between stakeholders, the use of process evaluations or a combination of all three. To date, however, there has been limited reporting of these methods in surgical settings and further research is required to ascertain their applicability and relevance [20, 21].
Randomised controlled trials in surgery can be difficult to design and conduct, and one of the reasons for this is that surgical interventions are complex. This complexity needs to be accounted for during trial design by considering how surgical interventions might be described, standardised and monitored. This paper provides practical guidance for surgeons and trialists to use when designing interventions in surgical RCTs to aid them in this process, so this information can be included a priori within trial protocols. This may help with the interpretation of trial results and the adoption of successful interventions into clinical practice. It is now necessary to test this guidance during the design phases of new surgical trials to assess its usability, usefulness and acceptability.
Medical Research Council
Idea-Development-Exploration-Assessment-Long term study
randomised controlled trial
Standard Protocol Items: Recommendations for Interventional Trials
Template for Intervention Description and Replication
Barkun JS, Aronson JK, Feldman LS, Maddern GJ, Strasberg SM, Altman DG, et al. Evaluation and stages of surgical innovations. Lancet. 2009;374:1089–96.
Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien PA, Reeves BC, et al. Challenges in evaluating surgical innovation. Lancet. 2009;374:1097–104.
McCulloch P, Altman DG, Campbell WB, Flum DR, Glasziou P, Marshall JC, et al. No surgical innovation without evaluation: the IDEAL recommendations. Lancet. 2009;374:1105–12.
Walwyn R, Roberts C. Therapist variation within randomised trials of psychotherapy: implications for precision, internal and external validity. Stat Methods Med Res. 2010;19:291–315.
Wells M, Williams B, Treweek S, Coyle J, Taylor J. Intervention description is not enough: evidence from an in-depth multiple case study on the untold role and impact of context in randomised controlled trials of seven complex interventions. Trials. 2012;13:95.
Medical Research Council. Developing and evaluating complex interventions: new guidance. London: MRC; 2008.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008;337:a1655.
Anderson R. New MRC, guidance on evaluating complex interventions. BMJ. 2008;337:a1937.
Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.
Cook JA. The challenges faced in the design, conduct and analysis of surgical randomised controlled trials. Trials. 2009;10:9.
Blencowe NS, Boddy AP, Harris A, Hanna T, Whiting P, Cook JA, et al., editors. A systematic review of intervention design and delivery within pragmatic and explanatory surgical RCTs. Philadelphia: Society for Clinical Trials; 2015. 102:1037–47.
Blencowe N, Mills N, Whiting P, Blazeby J. Providing adequate and practical descriptions in surgical trials. BMJ. 2013;347:f6143.
Avery KN, Barham CP, Berrisford R, Blazeby JM, Blencowe NS, Donovan J, et al. Understanding surgical interventions in RCTs: the need for better methodology. Lancet. 2013;381:27–8.
Carroll SL, McGillion M, Stacey D, Healey JS, Browne G, Arthur HM, et al. Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial. Trials. 2013;14:346.
Papachristofi O, Mackay JH, Powell SJ, Nashef SA, Sharples L. Impact of the anesthesiologist and surgeon on cardiac surgical outcomes. J Cardiothorac Vasc Anesth. 2014;28:103–9.
Devereaux PJ, Bhandari M, Clarke M, Montori VM, Cook DJ, Yusuf S, et al. Need for expertise based randomised controlled trials. BMJ. 2005;330:88.
Harrysson IJ, Cook J, Sirimanna P, Feldman LS, Darzi A, Aggarwal R. Systematic review of learning curves for minimally invasive abdominal surgery: a review of the methodology of data collection, depiction of outcomes, and statistical analysis. Ann Surg. 2014;260:37–45.
Treweek S, Zwarenstein M. Making trials matter: pragmatic and explanatory trials and the problem of applicability. Trials. 2009;10:37.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687.
Randell R, Greenhalgh J, Hindmarsh J, Dowding D, Jayne D, Pearman A, et al. Integration of robotic surgery into routine practice and impacts on communication, collaboration, and decision making: a realist process evaluation protocol. Implementation science : IS. 2014;9:52.
Blencowe N, Mills N, Donovan J, Blazeby J. Understanding the complexity of surgical interventions in rcts: the role of process evaluation in the operating theatre. Trials. 2013;14 Suppl 1:3.
Avery KN, Metcalfe C, Berrisford R, Barham CP, Donovan JL, Elliott J, et al. The feasibility of a randomised controlled trial of minimally invasive and open surgery for oesophageal cancer - the ROMIO (randomised oesophagectomy: minimally invasive or open) study: study protocol for a randomised controlled trial. Trials. 2014;15:200.
Rychetnik L, Frommer M, Hawe P, Shiell A. Criteria for evaluating evidence on public health interventions. J Epidemiol Community Health. 2002;56:119–27.
Carroll C, Patterson M, Wood S, Booth A, Rick J, Balain S. A conceptual framework for implementation fidelity. Implementation science: IS. 2007;2:40.
Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, et al. A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol. 2009;62:464–75.
Grant AM, Cotton SC, Boachie C, Ramsay CR, Krukowski ZH, Heading RC, et al. Minimal access surgery compared with medical management for gastro-oesophageal reflux disease: five year follow-up of a randomised controlled trial (REFLUX). BMJ. 2013;346:f1908.
Ferguson GG, Eliasziw M, Barr HWK, Clagett GP, Barnes RW, Wallace MC, et al. The North American symptomatic carotid endarterectomy trial: surgical results in 1415 patients. Stroke. 1999;30:1751–8.
Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AMH, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718–26.
Investigators UKET, Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D, et al. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med. 2010;362:1863–71.
Bennett-Guerrero E, Ferguson T, Lin M, Garg J, Mark DB, Scavo Jr VA, et al. Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trial. JAMA. 2010;304:755–62.
Powers WJ, Clarke WR, Grubb RL, Videen TO, Adams Jr HP, Derdeyn CP, et al. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: The carotid occlusion surgery study randomized trial. JAMA. 2011;306:1983–92.
Vons C, Barry C, Maitre S, Pautrat K, Leconte M, Costaglioli B, et al. Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. Lancet. 2011;377:1573–9.
Sovik TT, Taha O, Aasheim ET, Engstrom M, Kristinsson J, Bjorkman S, et al. Randomized clinical trial of laparoscopic gastric bypass versus laparoscopic duodenal switch for superobesity. Br J Surg. 2010;97:160–6.
Slim K. MRC CLASICC trial. The Lancet. 2005;366:712–3.
This work was supported by the MRC Network of Hubs for Trials Methodology Research (MR/L004933/1-R/N29), the MRC ConDuCT Hub (Collaboration and innovation for Difficult and Complex randomized controlled Trials In Invasive procedures - MR/K025643/1) and the MRC Biostatistics Hub (Cambridge). NSB is an NIHR Academic Clinical Lecturer. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. JAC holds a Medical Research Council UK Methodology fellowship (G1002292). The Health Services Research Unit at the University of Aberdeen is funded by the Chief Scientist Office of the Scottish Government Health Directorates.
MRC Hub for Trials Methodology Research Network Workshop Members
|Marion K Campbell3email@example.com|
|Elizabeth J Conroy4firstname.lastname@example.org|
|Caroline J Doré8email@example.com|
|Angelos G Kolias12firstname.lastname@example.org|
|Alan A Montgomery14email@example.com|
|Catrin Tudur Smith5firstname.lastname@example.org|
|Paula R Williamson5email@example.com|
1 Academic Department of Surgery, School of Cancer Sciences, Queen Elizabeth Hospital University of Birmingham, Edgbaston, Birmingham.
2 Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford.
3 Health Services Research Unit, University of Aberdeen, 3rd Floor, Health Sciences Building, Foresterhill, Aberdeen.
4 MRC North West Hub for Trials Methodology Research, Department of Biostatistics, University of Liverpool, Liverpool.
5 Warwick Clinical Trials Unit, Warwick Medical School, The University of Warwick, Coventry.
6 HTA NIHR Evaluation, Trials and Studies Co-ordinating Centre, University of Southampton, Southampton.
7 Centre for Surgical Research, School of Social and Community Medicine, University of Bristol.
8 Comprehensive Clinical Trials Unit University College London, Gower Street, London.
9 British Medical Journal, BMA House, Tavistock Square, London.
10 National Facial Oral and Oculoplastic Research Study Centre, Ground Floor, Gloucester House, St. Bartholomew's Hospital, West Smithfield, London.
11 Leeds Institute for Clinical Trials Research, University of Leeds, Clarendon Road, Leeds.
12 Division of Neurosurgery, Department of Clinical Neurosciences, Addenbrooke's Hospital & University of Cambridge, Cambridge.
13 Department of Oral and Maxillofacial Surgery, Bradford Teaching Hospitals NHS Foundation Trust, Bradford Royal Infirmary, Duckworth Lane, Bradford.
14 Faculty of Medicine and Health Sciences, Nottingham Medical School, Queen’s Medical Centre, Nottingham.
15 Department of Orthopaedic Surgery, James Cook University Hospital, Marton Road, Middlesbrough.
16 MRC Biostatistics Unit, Cambridge Institute of Public Health, Forvie Site, Robinson Way, Cambridge Biomedical Campus, Cambridge.
17 Midwifery and Allied Health Professions Research Unit, University of Stirling, Stirling University Innovation Park, Stirling.
The authors declare that they have no competing interests.
NSB, JMBr, JAC, CM, DGM, JN, LDS, ST and JMBl designed and coordinated the workshop, which was attended by the MRC Hub for Trials Methodology Research Network Workshop Members. The paper reflects workshop discussions and contributions from all workshop members. NSB and JMBl drafted the paper, which was revised with input from JMBr, JAC, CM, DGM, JN and LDS. All authors read and approved the final manuscript.
About this article
Cite this article
Blencowe, N.S., Brown, J.M., Cook, J.A. et al. Interventions in randomised controlled trials in surgery: issues to consider during trial design. Trials 16, 392 (2015). https://doi.org/10.1186/s13063-015-0918-4
- Surgical trials
- Trial design
- Complex interventions